An interview with Raffaella Giavazzi
Raffaella Giavazzi during her 5th Simon Karpatkin Memorial Lecture at the 9th ICTHIC in...
Most Read
Summary ESMO Clinical Practice Guideline for the management of venous thromboembolism in cancer patients
Venous thromboembolism (VTE) is the second cause of death in people with cancer, after cancer itself. Cancer and VTE...
Developmental hemostasis and its relevance to pediatric thrombosis
The coagulation system of neonates and children evolves with age, as evidenced by marked physiological differences in...
Cancer-related thrombosis in women
There is ample evidence confirming that cancer predisposes to thrombosis, while products of activation of the...
Updates in cancer-associated thrombosis
Our speakers, Luis Jara Palomares, Nikolaos Tsoukalas, and Nuria Muñoz Rivas, shared some updates on...
The USCAT study: a retrospective non-interventional study to examine long-term treatment of CAT
Patients with cancer are at high risk of venous thromboembolism (VTE) recurrence and major bleeding (1). Most...
How does clinical thrombosis presentation affect illness perception in patients with cancer-associated thrombosis?
Although thrombosis is the second cause of death in patients with cancer, after cancer itself, most of these patients...
ASCO Guideline Update on VTE Prophylaxis and Treatment in Patients with Cancer
The American Society of Clinical Oncology (ASCO) has been developing guidelines on cancer-associated thrombosis (CAT)...
The Management of Cancer-Associated Thrombosis: Are We at a Crossroad?
During this webinar, our three speakers, Professor Anna Falanga, Dr. Florian Scottè, and Dr. Luis Jara Palomares,...
Development, evaluation, and validation of an innovative electronic clinical risk prediction model for CAT
Thromboprophylaxis remains a critical concern in cancer patients initiating chemotherapy due to their heightened risk...